Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer

被引：0
|
作者：
Simon Fung
Yahiya Y. Syed
机构：
[1] Springer Nature,
来源：
Targeted Oncology | 2024年 / 19卷 / 1期
关键词：
D O I：
10.1007/s11523-023-01021-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 129
相关论文
共 50 条
  • [31] ID Expression in Advanced Biliary Tract Cancer
    Mueller, Michael J.
    Harder, Jan
    Hasskarl, Jens
    Gumpp, Vera
    Blum, Hubert E.
    Schmitt-Graeff, Annette
    Opitz, Oliver G.
    GASTROENTEROLOGY, 2009, 136 (05) : A619 - A619
  • [32] Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers
    Muddu, V.
    Shah, A.
    Raj, A.
    Bahl, A.
    Thirumalairaj, R.
    Ghosh, J.
    Ostwal, V.
    Rajappa, S.
    Vora, A.
    Lavingia, V.
    Sharma, A.
    Khan, A.
    Rohatgi, N.
    Mahajan, M.
    Chandrakanth, M.
    Ramaswamy, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S90 - S90
  • [33] The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: A real-world, retrospective, multicentric study
    Rimini, M.
    Persano, M.
    Foti, S.
    Fornaro, L.
    Lonardi, S.
    Niger, M.
    Tamburini, E.
    Lavacchi, D.
    Rapposelli, I. G.
    Martinelli, E.
    Garajova, I.
    Simionato, F.
    Camera, S.
    Rossari, F.
    Amadeo, E.
    Vitiello, F.
    Cascinu, S.
    Rimassa, L.
    Antonuzzo, L.
    Gardini, A. Casadei
    ANNALS OF ONCOLOGY, 2023, 34 : S1528 - S1528
  • [34] Durvalumab (DUR) effectiveness in advanced biliary tract cancer (aBTC) patients based on real-world data evidence.
    Rodriguez-Pascual, Jesus
    Hernandez, Gema
    Ugidos, Lisardo
    Parralejo, Alejandro
    Rodriguez-Castano, Juan Diego
    Serrano, Juan Jose
    Ayuso, Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 598 - 598
  • [35] TOURMALINE: A phase 3b study of durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer
    Vogel, Arndt
    He, Aiwu Ruth
    Oh, Do-Youn
    Macarulla, Teresa
    Dane, Aaron
    Nguyen, Binh
    Wetherill, Graham
    Baur, Boris
    Ikeda, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration
    Lu, Yunxin
    Jin, Yin
    Liu, Furong
    Wang, Zixian
    Zhou, Wen
    Zhang, Yang
    Bai, Bing
    Wang, Yun
    Wang, Zhiqiang
    Nie, Man
    Luo, Huiyan
    Wei, Xiaoli
    Liang, Chuqiao
    Guo, Guifang
    Qiu, Miaozhen
    Chen, Jianwen
    Liu, Yu
    Li, Shengping
    Li, Yuhong
    Wang, Fenghua
    Wang, Feng
    Chi, Peidong
    Zhang, Dongsheng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [37] Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective
    Tam, Vincent C.
    Ramjeesingh, Ravi
    Burkes, Ronald
    Yoshida, Eric M.
    Doucette, Sarah
    Lim, Howard J.
    CURRENT ONCOLOGY, 2022, 29 (10) : 7072 - 7085
  • [38] Applied precision cancer medicine in advanced biliary tract cancer
    Taghizadeh, H.
    Muellauer, L.
    Kieler, M.
    Prager, G.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
    Fiteni, Frederic
    Nguyen, Thierry
    Vernerey, Dewi
    Paillard, Marie-Justine
    Kim, Stefano
    Demarchi, Martin
    Fein, Francine
    Borg, Christophe
    Bonnetain, Franck
    Pivot, Xavier
    CANCER MEDICINE, 2014, 3 (06): : 1502 - 1511
  • [40] Current systemic treatment for advanced biliary tract cancer
    Vogel, Arndt
    Saborowski, Anna
    ONKOLOGIE, 2022, 28 (04): : 287 - 298
12345